Montecillo, Rosindo D.
HRN: 08-12-46 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/19/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
01/19/2023
01/25/2023
IV
600mg
Q8H
DM Foot, L
Waiting Final Action
Indication: Empiric Type of Infection: Bone & JointSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes